Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIBW 2948 in COPD with chronic bronchitis: impact on cough and sputum (CASA-Q)
2007-003742-15Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of BIBW 2948 BS in chronic obstructive pulmonary disease (COPD) and chronic bronchitis (CB) (4 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Change in CASA-Q symptom domain scores. Started Jul 2008; status: completed.
02
Drugs
BIBW 2948 BS
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)
Beyond the preview
Go deeper on 2007-003742-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003742-15.